Rifampin induced arthritis.
Azap
Ozlem Kurt
OK
Arslan
Hande
H
Timurkaynak
Funda
F
D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001168:Arthritis / Q000139:chemically induced*; D017347:Brucella melitensis; D002006:Brucellosis / Q000188:drug therapy / Q000382:microbiology; D004318:Doxycycline / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D013704:Temporomandibular Joint / Q000473:pathology; D013705:Temporomandibular Joint Disorders / Q000139:chemically induced*
D000900:Anti-Bacterial Agents; D004318:Doxycycline; D012293:Rifampin